219 related articles for article (PubMed ID: 30526553)
1. Deletion of the murine ortholog of the 8q24 gene desert has anti-cancer effects in transgenic mammary cancer models.
Homer-Bouthiette C; Zhao Y; Shunkwiler LB; Van Peel B; Garrett-Mayer E; Baird RC; Rissman AI; Guest ST; Ethier SP; John MC; Powers PA; Haag JD; Gould MN; Smits BMG
BMC Cancer; 2018 Dec; 18(1):1233. PubMed ID: 30526553
[TBL] [Abstract][Full Text] [Related]
2. The Oncogenic Potential of the Centromeric Border Protein FAM84B of the 8q24.21 Gene Desert.
Gu Y; Lin X; Kapoor A; Chow MJ; Jiang Y; Zhao K; Tang D
Genes (Basel); 2020 Mar; 11(3):. PubMed ID: 32183428
[No Abstract] [Full Text] [Related]
3. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB
Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742
[TBL] [Abstract][Full Text] [Related]
4. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB
Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729
[TBL] [Abstract][Full Text] [Related]
5. The gene desert mammary carcinoma susceptibility locus Mcs1a regulates Nr2f1 modifying mammary epithelial cell differentiation and proliferation.
Smits BM; Haag JD; Rissman AI; Sharma D; Tran A; Schoenborn AA; Baird RC; Peiffer DS; Leinweber DQ; Muelbl MJ; Meilahn AL; Eichelberg MR; Leng N; Kendziorski C; John MC; Powers PA; Alexander CM; Gould MN
PLoS Genet; 2013 Jun; 9(6):e1003549. PubMed ID: 23785296
[TBL] [Abstract][Full Text] [Related]
6. Integrated miRNA and mRNA expression profiling of mouse mammary tumor models identifies miRNA signatures associated with mammary tumor lineage.
Zhu M; Yi M; Kim CH; Deng C; Li Y; Medina D; Stephens RM; Green JE
Genome Biol; 2011 Aug; 12(8):R77. PubMed ID: 21846369
[TBL] [Abstract][Full Text] [Related]
7. Early parity significantly elevates mammary tumor incidence in MMTV-c-myc transgenic mice.
Jamerson MH; Johnson MD; Furth PA; Dickson RB
Transgenic Res; 2003 Dec; 12(6):747-50. PubMed ID: 14713205
[TBL] [Abstract][Full Text] [Related]
8. Identification of Jun loss promotes resistance to histone deacetylase inhibitor entinostat through Myc signaling in luminal breast cancer.
Tanioka M; Mott KR; Hollern DP; Fan C; Darr DB; Perou CM
Genome Med; 2018 Nov; 10(1):86. PubMed ID: 30497520
[TBL] [Abstract][Full Text] [Related]
9. The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice.
Elson A; Deng C; Campos-Torres J; Donehower LA; Leder P
Oncogene; 1995 Jul; 11(1):181-90. PubMed ID: 7624126
[TBL] [Abstract][Full Text] [Related]
10. Bax regulates c-Myc-induced mammary tumour apoptosis but not proliferation in MMTV-c-myc transgenic mice.
Jamerson MH; Johnson MD; Korsmeyer SJ; Furth PA; Dickson RB
Br J Cancer; 2004 Oct; 91(7):1372-9. PubMed ID: 15354213
[TBL] [Abstract][Full Text] [Related]
11. Mammary tumor development in MMTV-c-myc/MMTV-v-Ha-ras transgenic mice is unaffected by osteopontin deficiency.
Feng F; Rittling SR
Breast Cancer Res Treat; 2000 Sep; 63(1):71-9. PubMed ID: 11079161
[TBL] [Abstract][Full Text] [Related]
12. Expression profile of microRNAs in c-Myc induced mouse mammary tumors.
Sun Y; Wu J; Wu SH; Thakur A; Bollig A; Huang Y; Liao DJ
Breast Cancer Res Treat; 2009 Nov; 118(1):185-96. PubMed ID: 18777135
[TBL] [Abstract][Full Text] [Related]
13. Stat3 accelerates Myc induced tumor formation while reducing growth rate in a mouse model of breast cancer.
Jhan JR; Andrechek ER
Oncotarget; 2016 Oct; 7(40):65797-65807. PubMed ID: 27589562
[TBL] [Abstract][Full Text] [Related]
14. Deletion of the amino acid transporter Slc6a14 suppresses tumour growth in spontaneous mouse models of breast cancer.
Babu E; Bhutia YD; Ramachandran S; Gnanaprakasam JP; Prasad PD; Thangaraju M; Ganapathy V
Biochem J; 2015 Jul; 469(1):17-23. PubMed ID: 26173258
[TBL] [Abstract][Full Text] [Related]
15. Modulation of tumor fatty acids, through overexpression or loss of thyroid hormone responsive protein spot 14 is associated with altered growth and metastasis.
Wellberg EA; Rudolph MC; Lewis AS; Padilla-Just N; Jedlicka P; Anderson SM
Breast Cancer Res; 2014 Dec; 16(6):481. PubMed ID: 25472762
[TBL] [Abstract][Full Text] [Related]
16. Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis.
Zuo Y; Ulu A; Chang JT; Frost JA
Breast Cancer Res; 2018 May; 20(1):41. PubMed ID: 29769144
[TBL] [Abstract][Full Text] [Related]
17. Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice.
Maroulakou IG; Oemler W; Naber SP; Tsichlis PN
Cancer Res; 2007 Jan; 67(1):167-77. PubMed ID: 17210696
[TBL] [Abstract][Full Text] [Related]
18. The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis.
Aprelikova O; Chen K; El Touny LH; Brignatz-Guittard C; Han J; Qiu T; Yang HH; Lee MP; Zhu M; Green JE
Clin Epigenetics; 2016; 8():38. PubMed ID: 27081402
[TBL] [Abstract][Full Text] [Related]
19. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors.
Herschkowitz JI; Simin K; Weigman VJ; Mikaelian I; Usary J; Hu Z; Rasmussen KE; Jones LP; Assefnia S; Chandrasekharan S; Backlund MG; Yin Y; Khramtsov AI; Bastein R; Quackenbush J; Glazer RI; Brown PH; Green JE; Kopelovich L; Furth PA; Palazzo JP; Olopade OI; Bernard PS; Churchill GA; Van Dyke T; Perou CM
Genome Biol; 2007; 8(5):R76. PubMed ID: 17493263
[TBL] [Abstract][Full Text] [Related]
20. In vivo evidence supporting a metastasis suppressor role for Stard13 (Dlc2) in ErbB2 (Neu) oncogene induced mouse mammary tumors.
Basak P; Leslie H; Dillon RL; Muller WJ; Raouf A; Mowat MRA
Genes Chromosomes Cancer; 2018 Apr; 57(4):182-191. PubMed ID: 29218825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
